270P Germline BRCA1/2 pathogenic variants in Japanese patients with prostate cancer are predictive factors for androgen receptor-axis-targeted therapy or chemotherapy for castration-resistant prostate cancer
| Autor: | Maekawa, S., Takata, R., Matsuura, T., Ikarashi, D., Kato, R., Kanehira, M., Sugimura, J., Obara, W. |
|---|---|
| Zdroj: | In Annals of Oncology November 2023 34 Supplement 4:S1578-S1578 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|